drugset / Trial / NCT00027690
Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of gefitinib in treating patients who have persistent or recurrent endometrial cancer. Biological therapies such as gefitinib may interfere with the growth of tumor cells and slow the growth of endometrial cancer.
Timeline
- Start
- 2002-06
- Primary completion
- 2004-09
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | — | Oral |